Regulation of transcription of hypoxia-inducible factor-1α (HIF-1α) by heat shock factors HSF2 and HSF4

Oncogene

Volumn 30, Issue 22, 2011, Pages 2570-2580

  Chen, R ^a   Liliental, J E ^a   Kowalski, P E ^a,b   Lu, Q ^a,c   Cohen, S N ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

angiogenesis; heat shock element; heat shock factor; HIF 1 ; HSE; VEGF

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 2; HEAT SHOCK TRANSCRIPTION FACTOR 4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE LOCUS; GENETIC SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 79957910655     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.623     Document Type: Article

References (43)

1. Akerfelt M, Henriksson E, Laiho A, Vihervaara A, Rautoma K, Kotaja N et al. (2008). Promoter ChIP-chip analysis in mouse testis reveals Y chromosome occupancy by HSF2. Proc Natl Acad Sci USA 105: 11224-11229.
2. Akerfelt M, Trouillet D, Mezger V, Sistonen L. (2007). Heat shock factors at a crossroad between stress and development. Ann NY Acad Sci 1113: 15-27. (Pubitemid 350015004)
3. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM et al. (2001). Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93: 309-314. (Pubitemid 32219818)
4. Brahimi-Horn MC, Pouyssegur J. (2007). Harnessing the hypoxia-inducible factor in cancer and ischemic disease. Biochem Pharmacol 73: 450-457. (Pubitemid 44958373)
5. Busca R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B et al. (2005). Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-. J Cell Biol 170: 49-59.
6. Chang Y, Ostling P, Akerfelt M, Trouillet D, Rallu M, Gitton Y et al. (2006). Role of heat-shock factor 2 in cerebral cortex formation and as a regulator of p35 expression. Genes Dev 20: 836-847.
7. Chi NC, Karliner JS. (2004). Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res 61: 437-447. (Pubitemid 38210150)
8. Fraisl P, Mazzone M, Schmidt T, Carmeliet P. (2009). Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16: 167-179.
9. Fujimoto M, Izu H, Seki K, Fukuda K, Nishida T, Yamada S et al. (2004). HSF4 is required for normal cell growth and differentiation during mouse lens development. EMBO J23: 4297-4306. (Pubitemid 39546167)
10. Fujimoto M, Oshima K, Shinkawa T, Wang BB, Inouye S, Hayashida N et al. (2008). Analysis of HSF4 binding regions reveals its necessity for gene regulation during development and heat shock response in mouse lenses. J Biol Chem 283: 29961-29970.
11. Fujimoto M, Nakai A. (2010). The heat shock factor family and adaptation to proteotoxic stress. FEBS J277: 4112-4125.
12. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N et al. (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725. (Pubitemid 28436004)
13. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. (2002). Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 277: 29936-29944.
14. Jiang BH, Agani F, Passaniti A, Semenza GL. (1997). V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement ofHIF-1 in tumor progression. Cancer Res 57: 5328-5335. (Pubitemid 27516371)
15. Loison F, Debure L, Nizard P, le Goff P, Michel D, le Drean Y. (2006). Up-regulation of the clusterin gene after proteotoxic stress: implica-tion of HSF1-HSF2 heterocomplexes. Biochem J395: 223-231.
16. Lu Q, Wei W, Kowalski PE, Chang AC, Cohen SN. (2004). EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. Proc Natl Acad Sci USA 101: 17246-17251. (Pubitemid 39627805)
17. Mathew A, Mathur SK, Jolly C, Fox SG, Kim S, Morimoto RI. (2001). Stress-specific activation and repression of heat shock factors 1 and 2. Mol Cell Biol 21: 7163-7171. (Pubitemid 32953470)
18. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. (1997). Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcrip-tional element. Blood90: 3322-3331. (Pubitemid 27473400)
19. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. (1996). Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 56: 3436-3440. (Pubitemid 26251633)
20. Min JN, Zhang Y, Moskophidis D, Mivechi NF. (2004). Unique contribution of heat shock transcription factor 4 in ocular lens development and fiber cell differentiation. Genesis 40: 205-217. (Pubitemid 40110705)
21. Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J et al. (1999). Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett 460: 251-256. (Pubitemid 29495950)
22. Morimoto RI. (2008). Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427-1438. (Pubitemid 351793077)
23. Murphy LA, Wilkerson DC, Hong Y, Sarge KD. (2008). PRC1 associates with the hsp70i promoter and interacts with HSF2 during mitosis. Exp Cell Res 314: 2224-2230. (Pubitemid 351822336)
24. Nakai A, Tanabe M, Kawazoe Y, Inazawa J, Morimoto RI, Nagata K. (1997). HSF4, a new member of the human heat shock factor family which lacks properties of a transcriptional activator. Mol Cell Biol 17: 469-481. (Pubitemid 26425637)
25. Nardinocchi L, Puca R, Guidolin D, Belloni AS, Bossi G, Michiels C et al. (2009). Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth. Biochim Biophys Acta 1793: 368-377.
26. Ng YS, Krilleke D, Shima DT. (2006). VEGF function in vascular pathogenesis. Exp Cell Res 312: 527-537. (Pubitemid 43290330)
27. Olenyuk BZ, Zhang GJ, Klco JM, Nickols NG, Kaelin WG, Dervan PB. (2004). Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Natl Acad Sci USA 101: 16768-16773. (Pubitemid 39601313)
28. Ostling P, Bjork JK, Roos-Mattjus P, Mezger V, Sistonen L. (2007). Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem 282: 7077-7086. (Pubitemid 47093630)
29. Page EL, Robitaille GA, Pouyssegur J, Richard DE. (2002). Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 277: 48403-48409. (Pubitemid 35470797)
30. Pipinikas CP, Carter ND, Corbishley CM, Fenske CD. (2008). HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer. Biomarkers 13: 680-691.
31. Pirkkala L, Nykanen P, Sistonen L. (2001). Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 15: 1118-1131. (Pubitemid 32436297)
32. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D et al. (2004). Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 15: 4841-4853. (Pubitemid 39392201)
33. Pouyssegur J, Dayan F, Mazure NM. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443. (Pubitemid 44050138)
34. Sandqvist A, Bjork JK, Akerfelt M, Chitikova Z, Grichine A, Vourc'h C et al. (2009). Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. Mol Biol Cell 20: 1340-1347.
35. Schafer C, Clapp P, Welsh MJ, Benndorf R, Williams JA. (1999). HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells. Am J Physiol 277: C1032-C1043.
36. Semenza GL. (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732. (Pubitemid 37328811)
37. Somasundaram T, Bhat SP. (2004). Developmentally dictated expres-sion of heat shock factors: exclusive expression of HSF4 in the postnatal lens and its specific interaction with alphaB-crystallin heat shock promoter. J Biol Chem 279: 44497-44503. (Pubitemid 39430856)
38. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P, Jain RK. (2000). Vascular endothelial growth factor (VEGF) modula-tion by targeting hypoxia-inducible factor-1alpha-> hypoxia response element-> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60: 6248-6252.
39. Wartenberg M, Donmez F, Ling FC, Acker H, Hescheler J, Sauer H. (2001). Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J 15: 995-1005. (Pubitemid 32290787)
40. Xing H, Wilkerson DC, Mayhew CN, Lubert EJ, Skaggs HS, Goodson ML et al. (2005). Mechanism of hsp70i gene book-marking. Science 307: 421-423.
41. Yamamoto N, Takemori Y, Sakurai M, Sugiyama K, Sakurai H (2009). Differential recognition of heat shock elements by members of the heat shock transcription factor family. FEBS J 276: 1962-1974.
42. Zhang J, Goodson ML, Hong Y, Sarge KD. (2008). MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation. J Biol Chem 283: 7464-7469.
43. Zhang Y, Frejtag W, Dai R, Mivechi NF. (2001). Heat shock factor-4 (HSF-4a) is a repressor of HSF-1 mediated transcription. J Cell Biochem 82: 692-703.